Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (511-520 of 962) with videos related to

Pageof 97
Sort By:
Circulation|November 10, 2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisPhilippe Gabriel Steg, Stefan James, Robert A Harrington, et al.
European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Journal of the American College of Cardiology|July 30, 2021
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL CholesterolGregory G Schwartz, Michael Szarek, Vera A Bittner, et al.
Circulation|August 30, 2024
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice GuidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Human Molecular Genetics|February 25, 2016
Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndromeÅsa Johansson, Niclas Eriksson, Daniel Lindholm, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
International Journal of Cardiology|July 25, 2017
Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart diseaseOla Vedin, Emil Hagström, Ollie Östlund, et al.
Thrombosis and Haemostasis|April 7, 2017
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX studyWilliam A Parker, Deepak L Bhatt, Jayne Prats, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trialMartial Hamon, Pierre Coste, Arnoud Van't Hof, et al.
The American Journal of Cardiology|May 12, 2009
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)Arijit Dasgupta, Steven R Steinhubl, Deepak L Bhatt, et al.
Pageof 97

Showing results (511-520 of 962) with videos related to

Sort By:
Pageof 97
Circulation|November 10, 2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysisPhilippe Gabriel Steg, Stefan James, Robert A Harrington, et al.
European Heart Journal|August 30, 2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Journal of the American College of Cardiology|July 30, 2021
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL CholesterolGregory G Schwartz, Michael Szarek, Vera A Bittner, et al.
Circulation|August 30, 2024
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice GuidelinesWilliam E Boden, Raffaele De Caterina, Juan Carlos Kaski, et al.
Human Molecular Genetics|February 25, 2016
Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndromeÅsa Johansson, Niclas Eriksson, Daniel Lindholm, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
International Journal of Cardiology|July 25, 2017
Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart diseaseOla Vedin, Emil Hagström, Ollie Östlund, et al.
Thrombosis and Haemostasis|April 7, 2017
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX studyWilliam A Parker, Deepak L Bhatt, Jayne Prats, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trialMartial Hamon, Pierre Coste, Arnoud Van't Hof, et al.
The American Journal of Cardiology|May 12, 2009
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)Arijit Dasgupta, Steven R Steinhubl, Deepak L Bhatt, et al.
Pageof 97